Inve India ▾

Sagility share price & results

Sagility Limited· Information Technology

Results to
Sept 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Outsourced healthcare BPO for US payers, PBMs and providers — claims, clinical UM and RCM services.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue575 ₹ crore+16.9% YoYQuarterly, as filedQuarter to Sept 2026Revenue from operations as filed.
Operating margin26.0 %−6.0 pts YoYOperating profit / revenueQuarter to Sept 2026For the quarter; a change is in percentage points.
Net profit98.0 ₹ crore−11.7% YoYQuarterly, as filedQuarter to Sept 2026Profit after tax as filed.
Return on equity10.37 %+3.2 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin14.07 %−5.5 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)28.50 %+12.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Sept 2026

Guidance

What management said, and what became of it

2 of 6 judged targets kept · 9 open · verdicts reflect calls analysed to Q1 FY27.

Sagility Limited management guidance track record on Inve: 15 targets tracked across analysed earnings calls (2 achieved, 4 missed, 9 open).

TargetOriginal wordingSaidLatest callVerdict
FY25 Revenue Growth (CC)In line with H1 performance (~13.8% CC)
Call transcript, Q2 FY25 · 27 Nov 2024		Q2 FY25Q1 FY27:Target remains achieved from FY25.
Call transcript, Q1 FY27 · 21 Jul 2026		Achieved
FY26 Total Revenue Growth (CC)>20%
Call transcript, Q4 FY25 · 15 May 2025		Q4 FY25Q1 FY27:The final full-year FY26 growth figure was not explicitly reported in the Q1 FY27 results, leaving the final status against the 22.5% CC guidance unconfirmed.
Call transcript, Q1 FY27 · 21 Jul 2026		Ghosted
New Client Additions8-12 per year
Call transcript, Q2 FY25 · 27 Nov 2024		Q2 FY25Q1 FY27:Added 1 new logo in Q1 FY27 ($35.3M steady-state ACV signed across 18 existing clients and 1 new logo), which is on track for the annual target of 8-12 for FY27. Additionally, acquired 26 new clients via the CareSeed acquisition.
Call transcript, Q1 FY27 · 21 Jul 2026		On Track

Source: Inve Guidance Tracker for Sagility Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

4 of Sagility Limited's 15 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 12 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹44.5 +0.72% · +₹0.32

Last close 26 Oct 2026 · NSE · INR · Source: Inve

Performance −6.4% 1Y

₹35.0₹40.0₹45.0₹50.0₹55.0Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 29 Oct 2025Q3 FY26 — 28 Jan 2026Q4 FY26 — 12 May 2026Q1 FY27 — 21 Jul 2026

1Y: ₹47.52 on 24 Oct 2025 → ₹44.5. High ₹54.58 (30 Oct 2025), low ₹36.35 (23 Mar 2026).

Previous close
₹44.18
Market cap
₹20.8k Cr
52-week range
₹36.35 – ₹54.58
One year
−8.21%
Price to earnings (TTM to Sept 2026)
19.63×
Return on equity (TTM to Sept 2026)
10.37%

Overview

Symbol
NSE:SAGILITY
Exchange
NSE
Currency
INR

What Sagility Limited does

Based on the company's own presentations, annual report and earnings calls.

Sagility is a pure-play, 100% US-healthcare-focused business process management company that runs outsourced back-office and clinical-support operations for health insurers (payers), pharmacy benefit managers (PBMs) and healthcare providers. It earns fees by handling payer-side workflows such as member and provider lifecycle management, claims processing, prior authorization, utilization/case management and payment-integrity audits, as well as provider-side revenue-cycle management (benefit verification, coding, denials management and underpayment recovery). Delivery combines human operations staff (including nurses and clinicians) with proprietary AI/automation tools (e.g., SmarTec agents) across a multi-shore network spanning India, the Philippines, Jamaica, Colombia and the US. It also offers outcome-based managed-services and technology-platform ("Synchrony") engagements that bundle operations with client-side technology.

Segments

  • Payer & PBM Practice
  • Provider Practice
Healthcare associates (workforce)
40,000+
Delivery centers
35
Geographies of operation
5 (India, Philippines, Jamaica, Colombia, U.S.)
Clinicians and technology experts
4,100+
Healthcare clients served
80+
Top-10 U.S. payers served
7 of the top 10
Headquarters Bengaluru, Karnataka, IndiaEmployees 40,000 (March 2026) Company website

How the price took the results

close before → close after

Q1 FY27
+1.3%
21 Jul
Q4 FY26
−4.5%
12 May
Q3 FY26
−0.9%
28 Jan
Q2 FY26
+2.6%
29 Oct

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Sagility Limited

Free account: one company. Everything above stays public.

Write why you follow Sagility Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Information Technology companies

All Information Technology companies → · Information Technology earnings growth →

Learn to analyse Sagility Limited

Guides on how to read this kind of business and the numbers that matter.